Impact of interstitial brachytherapy (IB) or radical prostatectomy (RP) on quality of life (QL) of patients (pts) treated for localized prostate cancer (LPC): Medium-term outcomes from a prospective ...
Radiolabeled anti–prostate-specific membrane antigen (PSMA) monoclonal antibody J591 for metastatic castration-resistant prostate cancer (CRPC).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback